Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of antibiotics in cerebrospinal fluid of neonates with external ventricular drain
2018-002278-33Phase 4Active
- Sponsor
- Department of Clinical Pharmacology
- Start
- Aug 2018
- Modality
- Small Molecules, Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefuroxime, vancomycin, gentamicin, ampicillin, linezolid and 2 more in bacterial disease (7 cohorts), sponsored by Department of Clinical Pharmacology. Primary endpoints: Maximum concentration in cerebrospinal fluid, Time to maximum concentration in cerebrospinal fluid and 2 more. Started Aug 2018; status: active.
02
Drugs
cefuroximevancomycingentamicinampicillinlinezolid
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2018-002278-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002278-33.